Clinical Trial Update: An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke [Phase 2]

View source ↗

Summary

It reports the completion of an open-label Phase II trial evaluating the efficacy and safety of GXNPC-1 in patients with chronic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• GXNPC-1

Snippet

Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd. | Conditions: Chronic Stroke | Phase 2 | Status: COMPLETED